The serine proteinase inhibitors (serpins) are a superfamily of proteins with a diverse set of functions, including the control of blood coagulation, complement activation, programmed cell death and development. The most abundant serpins in human plasma are a,-antitrypsin (AAT) and a,-antichymotrypsin (ACT). During inflammation, circulating levels can increase by up to 3-fold for the former and by 4-5-fold for the latter. T h e major site for increased synthesis is the liver. Other tissues, such as the lung, are also capable of synthesizing AAT and ACT, and expression can be increased by up to 1 00-fold by cytokines. There is a tissue-specific promoter for the liver, and alternative promoters for other tissues that express AAT. Basal AAT expression is regulated by the synergistic action of the tissue-specific transcription factors hepatocyte nuclear factors l a and 4.
Introduction
a,-Antitrypsin (AAT; SERPIN Al) and a,-antichymotrypsin (ACT; SERPIN A3) [ l ] are the two most abundant serine proteinase inhibitors (serpins) in human plasma [2, 3] . AAT has a broad range of activities, including inhibition of the serine proteinases trypsin, chymotrypsin, thrombin, kallikrein and plasmin [2] . However, the primary role of AAT is to protect the lower respiratory tract from proteolytic destruction by neutrophil elastase [4] . A genetic deficiency of AAT is associated with a predisposition to develop chronic obstructive pulmonary disease, particularly for cigarette smokers [4] . Cigarette smoking results in neutrophil activation, with consequent release of neutrophil elastase into the lower respiratory tract.
A C T inhibits serine proteinases of the chymotrypsin type [5] , and its primary physiological function is to inhibit cathepsin G [6] . A C T has been shown to be a major constituent of the plaques associated with Alzheimer's disease [7] . The Alzheimer's neurotoxic amyloid peptide A/?-(1-42) interacts with A C T to stimulate both the formation and the disruption of A/?-( 1 4 2 ) fibrils in a concentration-dependent manner [8] .
Both AAT and A C T are positive acute-phase reactants, i.e. plasma concentrations increase as a result of inflammation. Both are synthesized primarily in the liver [2, 9, 10] . During the acutephase response, plasma concentrations of AAT increase by 2-4-fold and those of A C T increase by almost 5-fold [ 1 1,121. Other cell types are also able to produce one or both of these serpins, including lung alveolar epithelial (A549) cells [13] , monocytes [14] , human intestinal epithelial cells [15] and neuronal cells [16] .
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AAT
Interleukin-6 (IL-6) and related cytokines, such as oncostatin M (OSM), have the greatest stimulatory effect on the production of hepatocytederived AAT [3] . There are two types of DNA sequence that may mediate the response to IL-6. The type 1 elements (TT/GNNGT/CAAT/G) bind transcription factors that are members of the CCAAT enhancer binding protein (C/EBP) famMonocyte AAT production appears to be ily, particularly nuclear factor (NF)-IL6. Another primarily under the control of IL-6 [ 141, although C/EBP transcription factor, C/EBPa, is a negative lipopolysaccharide, interleukin-l/? (IL-1/?) and regulator and will compete with NF-IL6 for tumour necrosis factor a ( T N F a ) all cause a 2-binding. T h e type 2 element (TTCNNNGAA), 3-fold increase in AAT production by peripheral also known as the acute-phase response element (APRE), is involved in the JAK (Janus kinase)/ S T A T (signal transducers and activators of transcription) pathway. Up-regulation of S T A T 3 by IL-6 has been demonstrated in hepatocytes, and we have recently identified a S T A T 3 element in the 3' enhancer (N. Kalsheker, S. Morley and K. Morgan, unpublished work).
Interferon y and transforming growth factor p also modulate the hepatocyte response to IL-6 blood monocytes [21-231. Although lipopolysaccharide increases transcription approx. 2-fold, its main effects are probably to increase mRNA stability or translation rates, as the mean increase in protein has been estimated to be 8-fold [23] .
AAT gene regulation
T h e AAT and A C T genes are situated within a serpin cluster on chromosome 14q31-31.2 [24, 25] . T h e AAT gene is approx. 12.2 kb long, and is [17, 18] . In addition to cytokines having an effect organized into seven exons and six introns ( proposed initially [25] , but this was subsequently shown experimentally by primer extension and S1 nuclease mapping to occur six bases downstream of the proposed site [26] . In this review we will use the experimentally derived transcription start site, and this will be described as position + 1 (see Figure 1 ). Morgan, unpublished work) , leads preferentially to AAT transcripts with exon IB removed. It has been proposed that exon IB may act as a translational repressor, and removal may be important in the rapid local production of AAT [30] .
AAT transcripts
Corneal epithelial cells produce a unique 1.95 kb transcript, with no other transcripts being produced in this cell line [28] .
AAT promoter
The hepatocyte AAT promoter has a TATA-like sequence (TAAATA) [29] , located 20-25 bases (-25 to -20) upstream of the hepatocyte transcription start site. There is also a consensus sequence, a so-called B-recognition element (BRE), for transcription-activating factor IIB [31] . This element (CCCGTT) is located at positions -52 to -47, and may be functionally important, as it is in the region where the RNA polymerase holoenzyme binds to initiate transcription.
The region 500 bases upstream of the hepatocyte transcription start site contains at least three regulatory regions. A tissue-specific element at positions -137 to -37 upstream of the transcription start site is the dominant area for hepatocyte transcription [29, 32, 33] . Deletions or mutations in this region reduce transcription dramatically [34, 35] . This region is capable of activating a heterologous simian virus 40 promoter in Hep3B cells, but not in HeLa cells [35] . Hepatocyte nuclear factor-1 (HNF-l)/liver factor B1 (LF-Bl) binds across bases -80 to -61, and this region is described as the B region. HNF-1 can be resolved further using electrophoretic mobility shift assays into H N F -l a and HNF-1P, with H N F -l a migrating more slowly [36] . In the intestinal epithelium cell line Caco-2, HNF-1 CI and HNF-4 regulate AAT transcription by a synergistic interaction [ 151.
A second regulatory region, the X domain, is There are elements in the region -991 to -661 that appear to have a greater effect on transcription in Caco-2 cells than in HepG2 cells [15] . Although there are many potential candidate elements within this region, further studies will be required in order to elucidate which factors are relevant to AAT transcription.
3' AAT enhancer
There is a region 1200-1 300 bases downstream of the 3' end of exon V in which there are five putative binding regions for transcription factors [37] . This area was first highlighted following the report of a naturally occurring polymorphism at an Oct-1 binding site, destroying a recognition site By transfection studies, a 370 bp fragment which contains the five 3' putative transcription binding elements has been shown to be functionally active in an orientation-dependent manner [ 38,391.
T h e nucleotide sequence + 11 468 to + 11 475 (ATTTCGAT) has been shown to bind the transcription factor Oct-1 [38] . Reporter gene constructs showed a decrease in basal expression when the naturally occurring mutation described above was incorporated [38] . T h e mutation resulted in decreased Oct-1 binding, with diminished reporter gene activity in response to . This was shown to be the result of a loss of co-operative interaction between Oct-1 and the tissue-specific transcription factor NF-IL6 (CIEBPP) [40] .
[381.
Promoter
Interaction between the 5' and 3' AAT regulatory regions In HepG2 cells under basal conditions, there is a dominance of the 5' regulatory region, with no effect of the 3' enhancer region. However, following stimulation by IL-6, there is synergy between the 5' and 3' regions. This is lost if the naturally occurring polymorphism in the octamer site is present [39] , implying that the IL-6 response works via the 3' enhancer region, but requires interaction with the 5' region. Several mechanisms may be involved. There may be a direct interaction between the two sites, or interaction may be via intermediate transcription factors.
AAT expression in non-hepatic tissue
There are ten potential S p l binding elements within 1.4 kb upstream of the corneal transcription start site, and these play an important role in corneal AAT expression [28] . T h e significance of these sites in other tissues expressing AAT is not yet known.
Using macrophage microcell hybrids, DNase I hypersensitivity mapping suggested potential functionally active sites up to 25 kb upstream of the AAT hepatocyte transcription start site, with a significant cluster in a 5 kb fragment [40] that lies upstream of the monocyte transcription start site. This region warrants further investigation.
ACT
The A C T gene is approx. 12.8 kb bases long, and comprises five exons and four introns [45] (Figure 2 ) . A single transcription start site has been described [16] . There is a TATA-like sequence (TAAATAA) situated at positions -23 to -29 in relation to the transcription start site. Sequence comparison reveals a BRE-like sequence (GGG-GAGGA) at positions -51 to -44 upstream of . In astrocytes, synthesis can be stimulated by IL-1, T N F a and OSM [41] [42] [43] . IL-6 alone is unable to stimulate A C T production in astrocytes, due to the absence of cell surface IL-6 receptors. However, up-regulation can be achieved with a complex of IL-6 and soluble IL-6 receptor [43] . OSM also has a significant effect on A C T production in human lung alveolar cells [44] .
Cytokine-inducible elements in the ACT gene
These have been most studied in astrocytes. ACT expression in astrocytes is induced by OSM, but not by IL-6 or by the OSM-related cytokine leukaemia inhibitory factor, primarily as there is a lack of receptors for the latter. OSM mediates its effects mainly through the transcription factor S T A T 3. Two S T A T binding sites have been [lo].
Summary
The two serpins AAT and A C T both respond to IL-6 and related cytokines, and there are notable differences with respect to responses to IL-1. T h e elements required for specific gene expression under basal conditions and humoral control are being identified at high resolution. This, together with the definition of the boundaries of chromatin reassembly during gene expression, should further our understanding of how these genes are expressed.
